PLNTY is an epileptogenic tumor first described by Huse et al. in 2017, described as an epileptogenic histopathological tumor type with specific histological, immunohistochemical, and molecular profile combining an oligodendroglioma-like component, diffuse CD34 expression, and genetic alterations in the MAP kinase pathway (35). Here, CD34 is linked to neoplasm.